<DOC>
	<DOCNO>NCT00927212</DOCNO>
	<brief_summary>Atopic Dermatitis chronic non contagious disease cause itchy , inflamed skin . The purpose study evaluate safety efficacy topical AS101 ointment treatment Atopic dermatitis .</brief_summary>
	<brief_title>Topical Application AS101 Treatment Atopic Dermatitis</brief_title>
	<detailed_description>Atopic dermatitis ( AD ) common chronic inflammatory skin disease , affect 10-20 % child 2 % adult worldwide . The mechanism AD still completely understood , disorder appear result complex interaction immunological response , various susceptability gene , defect skin barrier function , host environmental factor infectious agent . AS101 non toxic potent immunomodulator show beneficial effect diverse pre clinical clinical study . Recently , AS101 show efficacy safety treatment mild moderate Psoriasis share AD relate immunological mechanism along AS101 ability decrease level interleukin know involved ith pathogenesis AD .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Ammonium trichloro ( dioxoethylene-O , O'- ) tellurate</mesh_term>
	<criteria>Diagnosed Atopic Dermatitis least 6 month prior enrollment . Diseased Body surface area ( BSA ) ≤ 20 % . Male Female ≥ 18 . Adequate general health . Signed Informed consent form patient his/her legal guardian . Patient must able willing comply protocol requirement . Patient unable provide fully inform consent . Pregnant breastfeeding female . Concomitant dermatologic medical condition ( ) may interfere patient 's response evaluation . Evidence infection target zone . Known sensitivity drug component . Immunocompromised patient . Concomitant medication : Topical corticosteroid within 2 week prior Day 1 visit ; Systemic steroids immunosuppressant within 1 month prior Day 1 visit ; *Systemic antihistamine antibiotic within 2 week prior Day 1 visit ; *Phototherapy within 4 week prior Day 1 visit ; Anticipated exaggerate exposure sunlight whole treatment period 4 week prior Day 1 visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>